Jefferies initiates coverage on TherapeuticsMD (NYSE: TXMD) with a Buy. PT $4.00.

The firm comments, "TXMD is focused ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE